Does OLOPATADINE Cause Product packaging quantity issue? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Product packaging quantity issue have been filed in association with OLOPATADINE (PATADAY ONCE DAILY RELIEF). This represents 0.5% of all adverse event reports for OLOPATADINE.
40
Reports of Product packaging quantity issue with OLOPATADINE
0.5%
of all OLOPATADINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From OLOPATADINE?
Of the 40 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLOPATADINE. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does OLOPATADINE Cause?
Treatment failure (4,685)
Drug ineffective (1,600)
Eye irritation (554)
Vision blurred (368)
Eye pruritus (317)
Hypersensitivity (269)
Ocular hyperaemia (260)
Eye pain (228)
Eye discharge (225)
Eye swelling (143)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which OLOPATADINE Alternatives Have Lower Product packaging quantity issue Risk?
OLOPATADINE vs OLUTASIDENIB
OLOPATADINE vs OMACETAXINE MEPESUCCINATE
OLOPATADINE vs OMADACYCLINE
OLOPATADINE vs OMALIZUMAB
OLOPATADINE vs OMAVELOXOLONE